Portfolio company
Neurolase
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a handheld laser device using artificial intelligence to help neurosurgeons identify cancerous brain tissue in real time during surgery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Refined Diagnostics
This company develops AI-powered laser imaging systems for real-time, stain-free tissue analysis and cancer diagnostics for surgeons, pathologists, and hospitals.
RebrAIn
The company develops artificial intelligence software to help neurosurgeons identify optimal brain targets for deep brain stimulation and lesioning treatments.
EnAcuity
This company develops artificial intelligence software that provides real-time hyperspectral imaging for surgeons performing minimally invasive procedures.
Clee Medical
The company develops an intraoperative imaging and navigation platform for neurosurgeons to perform minimally invasive brain surgery with real-time tissue and vasculature visualization.
Hypervision Surgical
The company develops an artificial intelligence powered hyperspectral imaging platform that provides real-time tissue analysis for surgeons during medical procedures.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
Monteris Medical
This company develops and manufactures robotically controlled laser ablation systems for neurosurgeons to treat brain tumours and epilepsy.
Coherence
This company develops minimally invasive implants and neurotechnology to monitor and manage cancer via real-time electrical signaling for patients with aggressive tumours.
